Ledger.Open graph →
SEC Form D · filed March 19, 2020

PharmaCCX, Inc

Offering
$7.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Peter Rice · Boston, MAExecArmen S. Solakhyan · Boston, MAExecJulia S. Bernstein · Boston, MADirectorBarath S. Subramanian · Boston, MADirectorNathan Sigworth · Boston, MAExec · DirectorJohn R. Wilson · VANCOUVER, British Columbia, CanadaDirectorMark Massaro · Boulder, CODirectorJoshua C. Stahl · Boulder, COExec · DirectorMarc G. Blythe · VANCOUVER, British Columbia, CanadaExecCraig G. Lindsay · VANCOUVER, British Columbia, CanadaExecDavid Brock · New York, NYExec · DirectorDaniele Zampa · St Petersburg, FLDirectorAndrew L. Faris · East Peoria, ILDirectorStacy M. Shunk · East Peoria, ILExecMark Tluszcz · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗